CN109123305A - 一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法 - Google Patents
一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法 Download PDFInfo
- Publication number
- CN109123305A CN109123305A CN201811028485.XA CN201811028485A CN109123305A CN 109123305 A CN109123305 A CN 109123305A CN 201811028485 A CN201811028485 A CN 201811028485A CN 109123305 A CN109123305 A CN 109123305A
- Authority
- CN
- China
- Prior art keywords
- crocodile
- parts
- powder
- peptide
- solid beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 title claims abstract description 91
- 241000270722 Crocodylidae Species 0.000 title claims abstract description 90
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 70
- 239000000843 powder Substances 0.000 title claims abstract description 61
- 235000013361 beverage Nutrition 0.000 title claims abstract description 27
- 239000007787 solid Substances 0.000 title claims abstract description 26
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 210000002784 stomach Anatomy 0.000 title claims abstract description 14
- 102000008186 Collagen Human genes 0.000 claims abstract description 45
- 108010035532 Collagen Proteins 0.000 claims abstract description 45
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 38
- 229920002752 Konjac Polymers 0.000 claims abstract description 22
- 235000013312 flour Nutrition 0.000 claims abstract description 22
- 229920001353 Dextrin Polymers 0.000 claims abstract description 21
- 239000004375 Dextrin Substances 0.000 claims abstract description 21
- 229920002472 Starch Polymers 0.000 claims abstract description 21
- 235000019425 dextrin Nutrition 0.000 claims abstract description 21
- 239000008107 starch Substances 0.000 claims abstract description 21
- 235000019698 starch Nutrition 0.000 claims abstract description 21
- 102000004407 Lactalbumin Human genes 0.000 claims abstract description 20
- 108090000942 Lactalbumin Proteins 0.000 claims abstract description 20
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 20
- VDTNNGKXZGSZIP-UHFFFAOYSA-N carbutamide Chemical compound CCCCNC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 VDTNNGKXZGSZIP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000013078 crystal Substances 0.000 claims abstract description 20
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 20
- 229920001202 Inulin Polymers 0.000 claims abstract description 19
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 19
- 229940029339 inulin Drugs 0.000 claims abstract description 19
- 239000000377 silicon dioxide Substances 0.000 claims abstract description 19
- 239000007788 liquid Substances 0.000 claims abstract description 13
- 239000011812 mixed powder Substances 0.000 claims abstract description 12
- 238000002156 mixing Methods 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 6
- 239000013612 plasmid Substances 0.000 claims abstract description 6
- 230000001954 sterilising effect Effects 0.000 claims abstract description 6
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 6
- 229920001436 collagen Polymers 0.000 claims description 17
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 10
- 102000057297 Pepsin A Human genes 0.000 claims description 5
- 108090000284 Pepsin A Proteins 0.000 claims description 5
- 239000012153 distilled water Substances 0.000 claims description 5
- 238000007654 immersion Methods 0.000 claims description 5
- 229940111202 pepsin Drugs 0.000 claims description 5
- 235000018102 proteins Nutrition 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 238000007789 sealing Methods 0.000 claims description 5
- 239000011780 sodium chloride Substances 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000010025 steaming Methods 0.000 claims description 4
- 239000000052 vinegar Substances 0.000 claims description 4
- 235000021419 vinegar Nutrition 0.000 claims description 4
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010469 Glycine max Nutrition 0.000 claims description 2
- 239000005862 Whey Substances 0.000 claims 2
- 102000007544 Whey Proteins Human genes 0.000 claims 2
- 108010046377 Whey Proteins Proteins 0.000 claims 2
- VDGJOQCBCPGFFD-UHFFFAOYSA-N oxygen(2-) silicon(4+) titanium(4+) Chemical compound [Si+4].[O-2].[O-2].[Ti+4] VDGJOQCBCPGFFD-UHFFFAOYSA-N 0.000 claims 2
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 claims 1
- 102000002322 Egg Proteins Human genes 0.000 claims 1
- 108010000912 Egg Proteins Proteins 0.000 claims 1
- 235000014103 egg white Nutrition 0.000 claims 1
- 210000000969 egg white Anatomy 0.000 claims 1
- 235000013601 eggs Nutrition 0.000 claims 1
- 235000015096 spirit Nutrition 0.000 abstract description 2
- 230000006870 function Effects 0.000 description 10
- 210000000988 bone and bone Anatomy 0.000 description 7
- 230000000694 effects Effects 0.000 description 5
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 description 4
- 108010038983 glycyl-histidyl-lysine Proteins 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 241001520221 Alligator sinensis Species 0.000 description 3
- 206010006002 Bone pain Diseases 0.000 description 3
- 241000723353 Chrysanthemum Species 0.000 description 3
- 235000007516 Chrysanthemum Nutrition 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 206010039984 Senile osteoporosis Diseases 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000011049 filling Methods 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 241000270728 Alligator Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 206010006956 Calcium deficiency Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 241000237636 Pheretima Species 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FLNXBVJLPJNOSI-UHFFFAOYSA-N 1-[2-[(4-chlorophenyl)-phenylmethoxy]ethyl]piperidine Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)OCCN1CCCCC1 FLNXBVJLPJNOSI-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 238000003457 Shi epoxidation reaction Methods 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- CFHNOIYLMYGHSO-UHFFFAOYSA-N [Mg].[P].[Zn].[Fe] Chemical compound [Mg].[P].[Zn].[Fe] CFHNOIYLMYGHSO-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229960002544 cloperastine Drugs 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000004153 glucose metabolism Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000749 insecticidal effect Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 108010048734 sclerotin Proteins 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
- A23J1/10—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from hair, feathers, horn, skins, leather, bones, or the like
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/52—Adding ingredients
- A23L2/66—Proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
本发明公开了一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法，鳄鱼肽蛋白粉固体饮料包括乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精；其制备方法包括以下步骤：S1、鳄鱼胶原蛋白肽粉的制备；S2、将乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精按照比例进行称取，放入粉碎机中粉碎成粉末状备用；S3、将步骤S2中制得的混合粉末倒入混合机内，干混5～10分钟，然后加入质粒液和酒精剂进行湿混10～15分钟；S4、将S3中所获得的混合粉末进行高温杀菌处理，然后低温干燥，即可得到鳄鱼肽蛋白粉固体饮料。
Description
技术领域
本发明涉及饮料领域，具体地说涉及一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法
背景技术
从现代科学上讲，鳄鱼骨、肉、血、油、内脏等全身各部富含蛋白质、DHA、卵磷脂、不饱和脂肪酸、铁锌磷镁等10种微量元素、18种以上氨基酸及维生素A、维生素E等，是一种科研价值、经济价值较高的动物。中医传统理论认为，地龙性寒，味咸。功能：清热、平肝、止喘、通络。归肝、胃、肺、膀胱经。功能清热平肝、熄风止痉、平喘、利尿、通络除痹。主治高热烦躁、惊痫抽搐、肺热喘咳、热结尿闭、痹痛肢麻、半身不遂，以及疮疡肿毒等证。主治高热狂燥，惊风抽搐，风热头痛，目赤、半身不遂等。地龙提供取液有良好的定咳平喘的作用。《本草纲目》曾记载其甲味辛、性温，有破血逐淤、消肿生肌之功效。《中华本草》第二十六卷载：扬子鳄(Alligatorsinensis)的甲片，药名鼍甲，有化瘀、消积、杀虫功能，主治瘕积聚，崩中带下，疮疥、恶疮，肠风痔疾。鳄鱼骨有强筋健骨、填精益髓等功能，对风湿骨痛有疗效。
目前市面上对鳄鱼系列产品生物学及营养学的精细化深开发以及研究应用在全球是少之又少。鳄鱼肽对小鼠具应激功能及造血机能，能显著提高小鼠在高温及低温环境中的耐受力，且鳄鱼肽有增强机体应激功能及升高血小板的作用。研究表明，鳄鱼肽含有大量的活性钙及磷等物质，可用于防治老年骨质疏松和婴幼儿缺钙等。鳄鱼肽有强筋健骨、填精益髓等功能，对风湿骨痛有极好的疗效。
发明内容
本发明目的是解决上述问题，更大地发挥出鳄鱼的营养价值和功效，提供一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法，可防治老年骨质疏松，能够增强其治疗骨质疏松的功效，强筋健骨，填精益髓，通和血脉。为了实现上述目的，本发明的技术方案是：
一种改善肠胃的鳄鱼肽蛋白粉固体饮料，包括乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精；其质量份数分别为：乳清蛋白4～6份、抗性糊精8～10份、菊粉12～14份、大豆分离蛋白8～10份、魔芋粉4～7份、非淀粉型结晶果糖2～4份、鳄鱼胶原蛋白肽粉15～20份、二氧化硅1～3份、食用香精1～3份。
进一步的，所述乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精的质量份数分别为：乳清蛋白5份、抗性糊精9份、菊粉13份、大豆分离蛋白9份、魔芋粉5份、非淀粉型结晶果糖3份、鳄鱼胶原蛋白肽粉18份、二氧化硅2份、食用香精2份
一种鳄鱼肽蛋白粉固体饮料的制备方法，包括以下步骤：
S1、鳄鱼胶原蛋白肽粉的制备；
S1.1、将预处理的鳄鱼皮放在粉碎机中进行粉碎，置于10～12倍体积的0.5mol/L的醋酸溶液中，加入鳄鱼皮质量的3％胃蛋白酶，浸泡24～48小时；
S1.2、将浸泡后的鳄鱼皮混合液过滤，并加入一定量的NaCl溶液使浓度为1mol/L在25～28℃恒温条件下浸泡12～24小时；
S1.3将步骤S1.2中得到的溶液离心处理20～30分钟，并弃去上清液后放入8～10倍体积的0.5mol/L的醋酸溶液中溶解，重新盐析和离心操作1次，得到鳄鱼胶原蛋白肽提取液；
S1.4、将鳄鱼胶原蛋白肽提取液置于醋酸溶液透析袋中，每4～6h换一次溶液，再用蒸馏水透析至中性，将其在低温下冷冻，然后移至干燥器内密封，迅速抽空并维持在抽空状态，6小时后即可得鳄鱼胶原蛋白肽粉末；
S2、将乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精按照比例进行称取，放入粉碎机中粉碎成粉末状备用；
S3、将步骤S2中制得的混合粉末倒入混合机内，干混5～10分钟，然后加入质粒液和酒精剂进行湿混10～15分钟；
S4、将S3中所获得的混合粉末进行高温杀菌处理，然后低温干燥，即可得到鳄鱼肽蛋白粉固体饮料。
与现有技术相比，本发明具有的优点和积极效果是：
本发明的鳄鱼肽蛋白粉固体饮料中含有从鳄鱼皮中提取的鳄鱼胶原蛋白肽，鳄鱼胶原蛋白肽含有大量的活性钙及磷等物质，可用于防治老年骨质疏松和婴幼儿缺钙等。鳄鱼肽有强筋健骨、填精益髓等功能，对风湿骨痛有疗效。且营养价值高，极易被机体吸收利用，具有正向调节免疫功能的能力。菊粉、魔芋粉等其他成分非常适用于葡萄糖代谢及肝功能不全的患者补充能量，且能促进有益细菌如双歧杆菌类生长繁殖，抑制有害菌生长，润肠通便，加快废物排出，具有改善人肠胃功能和代谢，降低血脂的功效。
具体实施方式
下面将结合本发明的实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
实施例1、一种改善肠胃的鳄鱼肽蛋白粉固体饮料，包括乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精；其质量份数分别为：乳清蛋白4份、抗性糊精8份、菊粉12份、大豆分离蛋白8份、魔芋粉4份、非淀粉型结晶果糖2份、鳄鱼胶原蛋白肽粉15份、二氧化硅1份、食用香精1份。
实施例2、一种改善肠胃的鳄鱼肽蛋白粉固体饮料，包括乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精；其质量份数分别为：乳清蛋白5份、抗性糊精9份、菊粉13份、大豆分离蛋白9份、魔芋粉6份、非淀粉型结晶果糖3份、鳄鱼胶原蛋白肽粉18份、二氧化硅2份、食用香精2份。
实施例3、一种改善肠胃的鳄鱼肽蛋白粉固体饮料，包括乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精；其质量份数分别为：乳清蛋白6份、抗性糊精10份、菊粉14份、大豆分离蛋白10份、魔芋粉7份、非淀粉型结晶果糖4份、鳄鱼胶原蛋白肽粉20份、二氧化硅3份、食用香精3份。
实施例4、一种鳄鱼肽蛋白粉固体饮料的制备方法，包括以下步骤：
S1、鳄鱼胶原蛋白肽粉的制备；
S1.1、将预处理的鳄鱼皮放在粉碎机中进行粉碎，置于10倍体积的0.5mol/L的醋酸溶液中，加入鳄鱼皮质量的3％胃蛋白酶，浸泡24小时；
S1.2、将浸泡后的鳄鱼皮混合液过滤，并加入一定量的NaCl溶液使浓度为1mol/L在25℃恒温条件下浸泡12小时；
S1.3将步骤S1.2中得到的溶液离心处理20分钟，并弃去上清液后放入8倍体积的0.5mol/L的醋酸溶液中溶解，重新盐析和离心操作1次，得到鳄鱼胶原蛋白肽提取液；
S1.4、将鳄鱼胶原蛋白肽提取液置于醋酸溶液透析袋中，每4h换一次溶液，再用蒸馏水透析至中性，将其在低温下冷冻，然后移至干燥器内密封，迅速抽空并维持在抽空状态，6小时后即可得鳄鱼胶原蛋白肽粉末；
S2、将乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精按照比例进行称取，放入粉碎机中粉碎成粉末状备用；
S3、将步骤S2中制得的混合粉末倒入混合机内，干混5分钟，然后加入质粒液和酒精剂进行湿混10分钟；
S4、将S3中所获得的混合粉末进行高温杀菌处理，然后低温干燥，即可得到鳄鱼肽蛋白粉固体饮料。
实施例5、一种鳄鱼肽蛋白粉固体饮料的制备方法，包括以下步骤：
S1、鳄鱼胶原蛋白肽粉的制备；
S1.1、将预处理的鳄鱼皮放在粉碎机中进行粉碎，置于11倍体积的0.5mol/L的醋酸溶液中，加入鳄鱼皮质量的3％胃蛋白酶，浸泡36小时；
S1.2、将浸泡后的鳄鱼皮混合液过滤，并加入一定量的NaCl溶液使浓度为1mol/L在26℃恒温条件下浸泡36小时；
S1.3将步骤S1.2中得到的溶液离心处理25分钟，并弃去上清液后放入9倍体积的0.5mol/L的醋酸溶液中溶解，重新盐析和离心操作1次，得到鳄鱼胶原蛋白肽提取液；
S1.4、将鳄鱼胶原蛋白肽提取液置于醋酸溶液透析袋中，每5h换一次溶液，再用蒸馏水透析至中性，将其在低温下冷冻，然后移至干燥器内密封，迅速抽空并维持在抽空状态，6小时后即可得鳄鱼胶原蛋白肽粉末；
S2、将乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精按照比例进行称取，放入粉碎机中粉碎成粉末状备用；
S3、将步骤S2中制得的混合粉末倒入混合机内，干混8分钟，然后加入质粒液和酒精剂进行湿混12分钟；
S4、将S3中所获得的混合粉末进行高温杀菌处理，然后低温干燥，即可得到鳄鱼肽蛋白粉固体饮料。
实施例6、一种鳄鱼肽蛋白粉固体饮料的制备方法，包括以下步骤：
S1、鳄鱼胶原蛋白肽粉的制备；
S1.1、将预处理的鳄鱼皮放在粉碎机中进行粉碎，置于12倍体积的0.5mol/L的醋酸溶液中，加入鳄鱼皮质量的3％胃蛋白酶，浸泡48小时；
S1.2、将浸泡后的鳄鱼皮混合液过滤，并加入一定量的NaCl溶液使浓度为1mol/L在28℃恒温条件下浸泡24小时；
S1.3将步骤S1.2中得到的溶液离心处理30分钟，并弃去上清液后放入10倍体积的0.5mol/L的醋酸溶液中溶解，重新盐析和离心操作1次，得到鳄鱼胶原蛋白肽提取液；
S1.4、将鳄鱼胶原蛋白肽提取液置于醋酸溶液透析袋中，每6h换一次溶液，再用蒸馏水透析至中性，将其在低温下冷冻，然后移至干燥器内密封，迅速抽空并维持在抽空状态，6小时后即可得鳄鱼胶原蛋白肽粉末；
S2、将乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精按照比例进行称取，放入粉碎机中粉碎成粉末状备用；
S3、将步骤S2中制得的混合粉末倒入混合机内，干混10分钟，然后加入质粒液和酒精剂进行湿混15分钟；
S4、将S3中所获得的混合粉末进行高温杀菌处理，然后低温干燥，即可得到鳄鱼肽蛋白粉固体饮料。
本发明中的制备方法在保证了鳄鱼胶原蛋白肽的营养成分没有损失的状况下，通过增加乳清蛋白、大豆分离蛋白等富含蛋白质的成分，使得本发明中的固体饮料中蛋白质含量更高，可以及时的给人体提供所需蛋白质，完全可以满足正在长身体的青少年及骨质疏松的老年人改善肠胃的需求，给人们的身体健康带来极为有益的功效。
Claims (3)
1.一种改善肠胃的鳄鱼肽蛋白粉固体饮料，其特征在于：所述固体饮料中包括乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精；其质量份数分别为：乳清蛋白4～6份、抗性糊精8～10份、菊粉12～14份、大豆分离蛋白8～10份、魔芋粉4～7份、非淀粉型结晶果糖2～4份、鳄鱼胶原蛋白肽粉15～20份、二氧化硅1～3份、食用香精1～3份。
2.如权利要求1所述的改善肠胃的鳄鱼肽蛋白粉固体饮料，其特征在于：所述乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精的质量份数分别为：乳清蛋白5份、抗性糊精9份、菊粉13份、大豆分离蛋白9份、魔芋粉5份、非淀粉型结晶果糖3份、鳄鱼胶原蛋白肽粉18份、二氧化硅2份、食用香精2份。
3.如权利要求1或2任一所述的鳄鱼肽蛋白粉固体饮料的制备方法，其特征在于：包括以下步骤：
S1、鳄鱼胶原蛋白肽粉的制备；
S1.1、将预处理的鳄鱼皮放在粉碎机中进行粉碎，置于10～12倍体积的0.5mol/L的醋酸溶液中，加入鳄鱼皮质量的3％胃蛋白酶，浸泡24～48小时；
S1.2、将浸泡后的鳄鱼皮混合液过滤，并加入一定量的NaCl溶液使浓度为1mol/L在25～28℃恒温条件下浸泡12～24小时；
S1.3将步骤S1.2中得到的溶液离心处理20～30分钟，并弃去上清液后放入8～10倍体积的0.5mol/L的醋酸溶液中溶解，重新盐析和离心操作1次，得到鳄鱼胶原蛋白肽提取液；
S1.4、将鳄鱼胶原蛋白肽提取液置于醋酸溶液透析袋中，每4～6h换一次溶液，再用蒸馏水透析至中性，将其在低温下冷冻，然后移至干燥器内密封，迅速抽空并维持在抽空状态，6小时后即可得鳄鱼胶原蛋白肽粉末；
S2、将乳清蛋白、抗性糊精、菊粉、大豆分离蛋白、魔芋粉、非淀粉型结晶果糖、鳄鱼胶原蛋白肽粉、二氧化硅、食用香精按照比例进行称取，放入粉碎机中粉碎成粉末状备用；
S3、将步骤S2中制得的混合粉末倒入混合机内，干混5～10分钟，然后加入质粒液和酒精剂进行湿混10～15分钟；
S4、将S3中所获得的混合粉末进行高温杀菌处理，然后低温干燥，即可得到鳄鱼肽蛋白粉固体饮料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811028485.XA CN109123305A (zh) | 2018-09-04 | 2018-09-04 | 一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811028485.XA CN109123305A (zh) | 2018-09-04 | 2018-09-04 | 一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109123305A true CN109123305A (zh) | 2019-01-04 |
Family
ID=64826969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811028485.XA Withdrawn CN109123305A (zh) | 2018-09-04 | 2018-09-04 | 一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109123305A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112056483A (zh) * | 2020-03-13 | 2020-12-11 | 浙江新维士生物科技有限公司 | 具有美容效果的复合胶原蛋白固体饮料及其制备方法 |
| CN117137147A (zh) * | 2023-07-26 | 2023-12-01 | 海南鳄珍鳄鱼产业科技有限公司 | 一种双龙肽饮品及制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102108098A (zh) * | 2010-08-11 | 2011-06-29 | 北京洪源澳达生物技术发展有限公司 | 一种鳄鱼胶原蛋白及其制备方法和用途 |
| CN104287049A (zh) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | 一种体重管理的代餐蛋白质粉固体饮料 |
| CN106962923A (zh) * | 2017-03-22 | 2017-07-21 | 深圳太太药业有限公司 | 一种用于体虚、病后、手术调养的海洋膳食组合物及其制备方法 |
-
2018
- 2018-09-04 CN CN201811028485.XA patent/CN109123305A/zh not_active Withdrawn
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102108098A (zh) * | 2010-08-11 | 2011-06-29 | 北京洪源澳达生物技术发展有限公司 | 一种鳄鱼胶原蛋白及其制备方法和用途 |
| CN104287049A (zh) * | 2014-11-07 | 2015-01-21 | 江苏艾兰得营养品有限公司 | 一种体重管理的代餐蛋白质粉固体饮料 |
| CN106962923A (zh) * | 2017-03-22 | 2017-07-21 | 深圳太太药业有限公司 | 一种用于体虚、病后、手术调养的海洋膳食组合物及其制备方法 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112056483A (zh) * | 2020-03-13 | 2020-12-11 | 浙江新维士生物科技有限公司 | 具有美容效果的复合胶原蛋白固体饮料及其制备方法 |
| CN117137147A (zh) * | 2023-07-26 | 2023-12-01 | 海南鳄珍鳄鱼产业科技有限公司 | 一种双龙肽饮品及制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104017700B (zh) | 一种调和养生酒及其制备方法 | |
| CN107568409A (zh) | 一种花胶活性肽的制备方法 | |
| CN106947674A (zh) | 一种复合滋补酒及其制作方法 | |
| CN109123305A (zh) | 一种改善肠胃的鳄鱼肽蛋白粉固体饮料及其制备方法 | |
| CN107242406A (zh) | 一种天然中草药运动饮料 | |
| CN106135449A (zh) | 一种豆干及其制作方法 | |
| CN108841530A (zh) | 一种健康养生酒及其制作方法 | |
| CN100574786C (zh) | 一种甲鱼制剂的生产工艺 | |
| CN103082240B (zh) | 一种胡萝卜参的加工方法 | |
| CN103897963A (zh) | 一种玛咖保健酒 | |
| CN103976205A (zh) | 一种改善内分泌的果冻及其制备方法 | |
| CN109837185A (zh) | 一种中药老米酒及其制备方法 | |
| CN104286384A (zh) | 一种大豆秸秆羔羊饲料及其制备方法 | |
| CN107594526A (zh) | 一种海藻胶为囊材的助消化软胶囊制剂的制备方法 | |
| CN103622090A (zh) | 一种能强肾健体的新型粉糊 | |
| CN109156531A (zh) | 一种补充营养的鳄鱼肽蛋白粉固体饮料及其制备方法 | |
| CN109123304A (zh) | 一种增强免疫力的鳄鱼肽蛋白粉固体饮料及其制备方法 | |
| CN104031805B (zh) | 一种秋季调和养生酒及其制备方法 | |
| CN106490179A (zh) | 一种保健豆腐及其制备方法 | |
| CN108949474A (zh) | 一种鳄鱼酒及其制备方法 | |
| CN102715241B (zh) | 一种营养全面、具有健脾作用的芡实双皮奶及其芡实藕粉与腐竹 | |
| CN102524800A (zh) | 一种复合黄瓜籽粉及其制备方法 | |
| CN106072668A (zh) | 排毒养颜的保健品及其制备方法 | |
| CN108690775B (zh) | 养生保健白酒的生产方法与养生保健白酒及其用法 | |
| CN110122818A (zh) | 亚健康人群滋补品鲫鱼养生保健汤剂及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information | ||
| CB02 | Change of applicant information |
Address after: 100124 2-15a-1, floor 15, building 2, yard 2, daxianting middle street, Chaoyang District, Beijing Applicant after: Health (Beijing) Health Industry Technology Co., Ltd. Address before: 100023 room 4, level 1, building 1, Guanyin Hui Garden, Chaoyang District, Beijing. Applicant before: Health (Beijing) Health Industry Technology Co., Ltd. |
|
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20210113 Address after: 572623 No.8, north side of Hongcao village, Sanjia Town, Dongfang City, Hainan Province Applicant after: Hainan crocodile Industry Technology Co.,Ltd. Address before: 100124 2-15a-1, 15th floor, building 2, yard 2, Dajiaoting middle street, Chaoyang District, Beijing Applicant before: BAISHENGKANG (BEIJING) HEALTH INDUSTRY TECHNOLOGY Co.,Ltd. |
|
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20190104 |